| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Leuven University Center for Metabolic Bone Diseases (S.B., D.V.), and Divisions of Geriatric Medicine (S.B.) and Endocrinology (R.B., D.V.), Katholieke Universiteit Leuven, B-3000 Leuven, Belgium; VU University Medical Center (P.L.), 1007 MB, Amsterdam, The Netherlands; Divisions of Aging and Rheumatology, Immunology, and Allergy (H.A.B.-F.), The Robert B. Brigham Arthritis and Musculoskeletal Diseases Clinical Research Center, Brigham and Womens Hospital, Boston, Massachusetts 02115; and Department of Orthopaedics and Traumatology (P.H.), Vrije Universiteit Brussel, B-1090 Brussels, Belgium
Address all correspondence and requests for reprints to: S. Boonen, M.D., Ph.D., Leuven University Center for Metabolic Bone Diseases and Division of Geriatric Medicine, University Hospital Leuven, Herestraat 49, B-3000 Leuven, Belgium. E-mail: steven.boonen{at}uz.kuleuven.ac.be.
Purpose: The purpose of this study was to extend the metaanalysis of Bischoff-Ferrari et al., which found that 700800 IU/d vitamin D reduced hip fracture risk in elderly individuals by 25%, by defining the need for additional calcium supplementation in individuals receiving vitamin D for the prevention of hip fractures.
Data Sources: MEDLINE and EMBASE.com (search terms: "vitamin D" and "hip fracture"), bibliographies of articles retrieved, and the authors reference files were used as data sources.
Study Selection: Selected studies were randomized controlled trials (RCTs) of oral vitamin D with or without calcium supplementation vs. placebo/no treatment in postmenopausal women and/or older men (
50 yr) specifically reporting a risk of hip fracture.
Data Extraction: Independent extraction was performed by two authors using predefined criteria, including study quality indicators.
Data Synthesis: All pooled analyses are based on random-effects models. Based on four RCTs (9083 patients), the pooled relative risk (RR) of hip fracture for vitamin D alone was 1.10 [95% confidence intervals (CI) 0.89, 1.36]. No between-trial heterogeneity was observed. For the six RCTs (45,509 patients) of vitamin D with calcium supplementation, the pooled RR for hip fracture was 0.82 (95% CI 0.71, 0.94). There was no heterogeneity between trials. In an adjusted indirect comparison of the summary RRs from the two metaanalyses, the RR for hip fracture for vitamin D with calcium vs. vitamin D alone was 0.75 (95% CI 0.58, 0.96).
Conclusions: Our analyses, designed to extend the findings of Bischoff-Ferrari et al., suggest that oral vitamin D appears to reduce the risk of hip fractures only when calcium supplementation is added.
This article has been cited by other articles:
![]() |
R. Scragg and C. A. Camargo Jr Scragg and Camargo Respond to "Physical Activity and Vitamin D" Am. J. Epidemiol., June 25, 2008; (2008) kwn166v1. [Full Text] [PDF] |
||||
![]() |
P. Hadji, J.-J. Body, M. S. Aapro, A. Brufsky, R. E. Coleman, T. Guise, A. Lipton, and M. Tubiana-Hulin Practical guidance for the management of aromatase inhibitor-associated bone loss Ann. Onc., April 29, 2008; (2008) mdn164v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W Nieves and R. Lindsay Calcium and fracture risk Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1579 - 1580. [Full Text] [PDF] |
||||
![]() |
H. A Bischoff-Ferrari, B. Dawson-Hughes, J. A Baron, P. Burckhardt, R. Li, D. Spiegelman, B. Specker, J. E Orav, J. B Wong, H. B Staehelin, et al. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1780 - 1790. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Smith, F. Anderson, H. Raphael, P. Maslin, S. Crozier, and C. Cooper Effect of annual intramuscular vitamin D on fracture risk in elderly men and women a population-based, randomized, double-blind, placebo-controlled trial Rheumatology, December 1, 2007; 46(12): 1852 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Francis The Vitamin D Paradox Rheumatology, December 1, 2007; 46(12): 1749 - 1750. [Full Text] [PDF] |
||||
![]() |
R. Bouillon, A. W. Norman, P. Lips, R. C. Cava, A. N. D. Javier, W. R. Howe, R. Dellavalle, G. I. Baroncelli, and M. F. Holick Vitamin D Deficiency N. Engl. J. Med., November 8, 2007; 357(19): 1980 - 1982. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |